SCHEMBL5668928

SCHEMBL5668928

CC(OCn1c(=O)c(-c2cccc3c(=O)n(CC(F)(F)F)sc23)nc2c(O)cccc21)[Si](C)(C)C

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL5668925 0.85 NPC1 (0.39) —
SCHEMBL5667336 0.66 CDK4 (0.45) —
SCHEMBL13865878 0.64 NPC1 (0.38) —
SCHEMBL13870888 0.63 NPC1 (0.35) —
SCHEMBL5667412 0.61 CDK4 (0.42) —
SCHEMBL5669493 0.61 NPC1 (0.39) —
SCHEMBL13866107 0.59 NPC1 (0.36) —
SCHEMBL13865832 0.57 KDM4E (0.35) —
SCHEMBL6080442 0.52 MAPK1 (0.51) —
SCHEMBL6657286 0.50 TLR8 (0.54) —

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7148224-B2 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis BANYU PHARMACEUTICAL CO., LTD. (JP) 2006-12-12 — — US disclosed
US-20050176719-A1 Novel pyrazinone derivatives MSD K.K. (JP) 2005-08-11 — — US disclosed
US-6914062-B2 Pyrazinone derivatives BANYU PHARMACEUTICAL CO., LTD. (JP) 2005-07-05 — — US disclosed
EP-1295878-B1 PYRAZINONE DERIVATIVES BANYU PHARMA CO LTD (JP) 2004-09-15 — — EP disclosed
US-20030203907-A1 An enzyme inhibitors of cyclin-dependent kinases, antitumor agents; chemical intermediate synthesis MSD K.K. (JP) 2003-10-30 — — US disclosed
EP-1295878-A1 NOVEL PYRAZINONE DERIVATIVES BANYU PHARMACEUTICAL CO., LTD. (JP) 2003-03-26 — — EP disclosed
Send feedback